… Mazard contributed equally to this article. … T. Mazard received a commercial research
grant from Roche. No potential conflicts of interest were disclosed by the other authors. …

Mitochondria are considered as the power-generating units of the cell due to their key role in
energy metabolism and cell signaling. However, mitochondrial components could be found …

Colorectal tumors become more heterogeneous after progression on EGFR-inhibitors by
developing multiple independent mutations. Upon discontinuation of treatment, the mutant …

Doublet or triplet chemotherapy regimens in combination with anti–epidermal growth factor
receptor (anti-EGFR) monoclonal antibodies (mAb), such as cetuximab or panitumumab, or …

Purpose: Circulating cell-free DNA (ccfDNA) is a valuable source of tumor material obtained
from a simple blood sampling that enables noninvasive analysis of the tumor genome. Our …

The management of patients with colorectal cancer (CRC) and potentially resectable liver
metastases (LM) requires quick assessment of mutational status and of response to pre-…

… T. Mazard reports grants and non-financial support from Amgen; personal fees and non-financial
support from Merck Serono; personal fees from Sandoz, Sanofi, BMS, Bayer; non-…

… with MSI/dMMR are characterized by a high tumor mutational burden, with highly
immunogenic neoantigens arising from frameshift mutation and by a high infiltration of cytotoxic T …

To unequivocally address their unresolved intimate structures in blood, we scrutinized the
size distribution of circulating cell-free DNA (cfDNA) using whole-genome sequencing (WGS) …

Circulating tumor cells (CTCs) are important clinical indicators for prognosis and treatment
efficacy. However, CTC investigation is hampered by their low number, making the …